Cancer & Oncology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 4.
Study: Alcohol Is Leading Preventable Cause Of Cancer In U.S.
BOSTON (CBS) – Researchers in Boston have taken a good hard look at alcohol and cancer deaths.
Dr. Timothy Naimi, at Boston University School of Medicine, says this is the first time in 30 years that researchers have looked closely at alcohol and cancer deaths.
WBZ NewsRadio 1030′s Diane Stern reports
Download: alcohol-cancer-doc-web-extended.mp3
“When it comes to alcohol consumption and cancers, clearly excessive drinking is the riskiest type of drinking,” Dr. Naimi said. “But when it comes to cancer, there is no safe level of alcohol consumption.”
Res...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 14, 2013 Category: Consumer Health News Authors: deanreddington Tags: Health Heard On WBZ NewsRadio 1030 Sports Syndicated Local Watch Listen Alcohol alcohol cancer Boston University School Of Medicine Diane Stern Dr. Timothy Naimi Source Type: news
Clues Found to Prostate Cancer Upgrading
ORLANDO (MedPage Today) -- Almost a third of men on active surveillance for prostate cancer had an upgrade in Gleason pathology grade during follow-up, biopsy results for almost 600 patients showed.
Source: MedPage Today State Required CME - February 14, 2013 Category: Consumer Health News Source Type: news
Alcohol Blamed for 1 in Every 30 Cancer Deaths: Study
Research suggests that even a little drinking can raise odds for malignancy
Source: WebMD Health - February 14, 2013 Category: Consumer Health News Source Type: news
ASCO GU Symposium Daily News Expert Editorial
Genitourinary Cancers Symposium Daily News Expert Editorial by Mark J. Ratain, MD (see page 20).
02/14/2013
Source: Kidney Cancer Association - February 14, 2013 Category: Cancer & Oncology Source Type: news
Alcohol Blamed for 1 in Every 30 Cancer Deaths
Research suggests that even a little drinking can raise odds for malignancy
Source: HealthDay
Related MedlinePlus Pages: Alcohol, Cancer, Health Statistics
Source: MedlinePlus Health News - February 14, 2013 Category: Consumer Health News Source Type: news
Panel Gives Mixed Review to MRI Contrast
(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee recommended approval for a novel gadolinium-based MRI contrast agent in adults and children older than 2, but not for younger children.
Source: MedPage Today Hematology/Oncology - February 14, 2013 Category: Hematology Source Type: news
Cephalon wins US court appeal on cancer drug patents
NEW YORK (Reuters) - A federal appeals court on Thursday said two Cephalon Inc patents related to the cancer drug Fentora are valid, overturning part of a lower court order against the unit of Israel's Teva Pharmaceutical Industries Ltd.
Source: Reuters: Health - February 14, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Tech guru offers privacy tips when using medical apps
“Personal medical records like immunizations and cancer results are increasingly kept on smartphone apps, but experts say there are privacy issues to consider. Apps that store personal data on the device itself can be risky if it’s stolen or hacked, technology expert Don Tapscott (pictured) warns.
“You want your data stored in the cloud where it [...]
Source: ICMCC: The International Council on Medical and Care Compunetics - February 14, 2013 Category: Information Technology Authors: Lodewijk Tags: News Applications Cloud Immunization Privacy Source Type: news
Minnesota Partnership Awards Ovarian and Brain Cancer, TB Research Grants
Ovarian and brain cancer, tuberculosis, imaging for Alzheimer's disease and new approaches to treating glaucoma are the serious medical problems that five partnering teams from Mayo Clinic and the University of Minnesota will focus on over the next two years, thanks to grants from the Minnesota Partnership for Biotechnology and Medical Genomics.
Source: Mayo Clinic Research News - February 14, 2013 Category: Research Authors: Mayo Clinic Source Type: news
Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia
But the risk to any one patient is small, experts said, and treatments can be altered to minimize hazard
Source: The Doctors Lounge - Oncology - February 14, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Research, News, Source Type: news
16 Cases of Kidney Damage in 6 States From Synthetic Pot: CDC
Five people needed their blood filtered after using designer drugs such as 'Spice,' researchers report
Source: The Doctors Lounge - Oncology - February 14, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Nephrology, Oncology, Dependence, News, Source Type: news
Lung Cancer To Overtake Breast Cancer Among Women In Europe
Within the next decade lung cancer is predicted to be the main cause of cancer deaths in European women, according to a recent study published in the journal Annals of Oncology. Lung cancer has already become the main cause of cancer death among women in the UK and Poland, overtaking breast cancer. In fact, according to research carried out by investigators from King's College London, over the next thirty years lung cancer among females will rise thirty times faster than males. Researchers from Italy and Switzerland estimate that close to 1...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
U.S. appeals court says Watson did not infringe Cephalon patents
NEW YORK (Reuters) - A U.S. appeals court reversed part of a ruling in favor of Watson Pharamaceutials over Cephalon in patent lawsuit over the cancer drug Fendora.
Source: Reuters: Health - February 14, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia
But the risk to any one patient is small, experts said, and treatments can be altered to minimize hazard
Source: HealthDay
Related MedlinePlus Pages: Acute Myeloid Leukemia, Cancer Chemotherapy
Source: MedlinePlus Health News - February 14, 2013 Category: Consumer Health News Source Type: news
Key Molecule Suppresses Growth of Cancerous Liver Tumors, Mayo Study Finds
A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found.
Source: Mayo Clinic Research News - February 14, 2013 Category: Research Authors: Mayo Clinic Source Type: news
Highlights from the Genitourinary Cancers Symposium
Listen to the podcast
02/14/2013
Source: Kidney Cancer Association - February 14, 2013 Category: Cancer & Oncology Source Type: news
Zambia: Cervical Cancer and HIV in Women
[CSIS]Cervical cancer kills an estimated 275,000 women every year, 85 percent of whom are in developing countries. The link between HIV and cervical cancer is direct and deadly; HIV-infected women who are also infected with specific types of human papilloma virus (HPV) are 4-5 times more susceptible to cervical cancer than HIV-negative women. This has important implications for HIV programs, especially in countries with significant HIV epidemics.
Source: AllAfrica News: HIV-Aids and STDs - February 14, 2013 Category: Infectious Diseases Source Type: news
NIH study finds increases in risk of certain leukemias related to treatment
A new study describes the pattern of risk for one form of cancer, acute myeloid leukemia (AML), that has risen over the past three decades for adults who have previously been treated with chemotherapy for other forms of cancer, notably non-Hodgkin’s lymphoma.
Source: National Institutes of Health (NIH) News Releases - February 14, 2013 Category: American Health Source Type: news
Supercomputer, Formerly on Jeopardy!, Now in Cancer ClinicSupercomputer, Formerly on Jeopardy!, Now in Cancer Clinic
The supercomputer now has an oncology application. Medscape Medical News
Source: Medscape Today Headlines - February 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Supercomputer From Gameshow Now in Cancer ClinicSupercomputer From Gameshow Now in Cancer Clinic
The supercomputer now has an oncology application. Medscape Medical News
Source: Medscape Today Headlines - February 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Watson, Formerly on Jeopardy!, Now in the Cancer ClinicWatson, Formerly on Jeopardy!, Now in the Cancer Clinic
The supercomputer now has an oncology application. Medscape Medical News
Source: Medscape Today Headlines - February 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Bilateral renal cell carcinoma in autosomal dominant polycystic kidney disease
The association of autosomal dominant polycystic kidney disease with renal cell carcinoma is infrequent. A case of bilateral renal cell carcinoma in conjunction with autosomal dominant polycystic kidney disease is presented. The discussion emphasizes pertinent diagnostic and therapeutic considerations.02/14/2013
Source: Kidney Cancer Association - February 14, 2013 Category: Cancer & Oncology Source Type: news
Well: Life, Interrupted: Crazy, Unsexy Cancer Tips
Every few weeks I host a "girls' night" at my apartment in Lower Manhattan with a group of friends who are at various stages in their cancer treatments. But one topic that doesn't come up as often as you might think -- particularly at a gathering of women in their early 20s and 30s -- is sex.
Source: NYT Health - February 14, 2013 Category: Consumer Health News Authors: By SULEIKA JAOUAD Tags: Sex Women and Girls Suleika Jaouad Friendship Cancer Voices Featured Life Interrupted Life, Interrupted Source Type: news
Rise In Lung Cancer Deaths Among European Women
Lung cancer is likely to overtake breast cancer as the main cause of cancer death among European women by the middle of this decade, according to new research published in the cancer journal Annals of Oncology [1]. In the UK and Poland it has already overtaken breast cancer as the main cause of cancer deaths in women. The study by researchers in Italy and Switzerland predicts that just over 1.3 million people will die from cancer (737,747 men and 576,489 women) in the 27 countries of the European Union in 2013...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Lung Cancer Source Type: news
Ability To Tune Gene Activity Will Permit Refined Research For Drug Resistance, Cancer
Scientists who built a synthetic gene circuit that allowed for the precise tuning of a gene's expression in yeast have now refined this new research tool to work in human cells, according to research published online in Nature Communications. "Using this circuit, you can turn a gene from completely off to completely on and anywhere between those two extremes in each cell at once. It's a nice tool if you want to know what happens at intermediate levels of gene expression...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Genetics Source Type: news
Few Negative Reactions Expressed By Consumers To The Results Of Genetic Testing For Cancer Mutations
A 23andMe study of consumers' reactions to genetic testing found that even when the tests revealed high-risk mutations in individuals, those individuals had few negative reactions to the news. Instead of inducing serious anxiety, the test results prompted people to take positive steps, including follow-up visits with a doctor and discussions with family members who could also be at risk...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Genetics Source Type: news
Improved Understanding Of The Molecular Machinery Of Cancer
Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have provided important new details into the activation of the epidermal growth factor receptor (EGFR), a cell surface protein that has been strongly linked to a large number of cancers and is a major target of cancer therapies...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Combining Synthetic, Natural Toxins Could Disarm Cancer, Drug-Resistant Bacteria
Cancer researchers from Rice University suggest that a new man-made drug that's already proven effective at killing cancer and drug-resistant bacteria could best deliver its knockout blow when used in combination with drugs made from naturally occurring toxins. "One of the oldest tricks in fighting is the one-two punch -- you distract your opponent with one attack and deliver a knockout blow with another," said José Onuchic of Rice's Center for Theoretical Biological Physics (CTBP). "Combinatorial drug therapies employ that strategy at a cellular level...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Possible Alternative Treatment To Significantly Reduce The Adverse Effects Of Chemotherapy In Lymphoid Leukemia
An international research team coordinated at the IRCM in Montréal found a possible alternative treatment for lymphoid leukemia. Led by Dr. Tarik Möröy, the IRCM's President and Scientific Director, the team discovered a molecule that represents the disease's "Achilles' heel" and could be targeted to develop a new approach that would reduce the adverse effects of current treatments such as chemotherapy and radiation therapy. The study's results are being published in the prestigious scientific journal Cancer Cell...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news
African-American Women With Benign Breast Disease May Be At Greater Risk For Cancer
A Wayne State University researcher has identified characteristics in benign breast disease associated with future cancer risk in African-American women. Michele Cote, Ph.D., associate professor of oncology in the School of Medicine and the Barbara Ann Karmanos Cancer Institute, recently reviewed data from about 1,400 20- to 84-year-old African-American women who underwent breast biopsies between 1997 and 2000. Researchers identified biopsies that showed benign breast disease (BBD) and also tracked subsequent breast cancers...
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
13.02.13: Not intended for U.S. and UK Media - Castration-Resistant Prostate Cancer with Bone Metastases:
Radium-223 Dichloride Granted Priority Review by U.S. FDAmehr ...
Source: Bayer IR Newsfeed: Events - February 14, 2013 Category: Pharmaceuticals Source Type: news
Eastern Clinical Trials Russia CRO Passes EMA Inspection
Eastern Clinical Trials Russia CEE CRO passes EMA Inspection for oncology clinical trial.(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10421281.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
University of Colorado Cancer Center Study Shows That Problem-Solving...
Multi-site clinical trial proves the effectiveness of Bright IDEAS problem-solving training in reducing symptoms of posttraumatic stress in mothers of children diagnosed with cancer. Materials...(PRWeb February 12, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10424402.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA...
Workshop will discuss minimal residual disease (MRD) as a possible response in group of hematological malignancies(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/TalkPoint/FDAAC/prweb10418062.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Neurological Wellness Center Criticizes the U.S. Patent Office for...
The Newly-Released Award-Winning Movie Burzynski Documenting the U.S. Patent Office’s Alleged Collusion with the FDA to Enrich Big Pharma by Denying Americans Access to Life-Saving Cancer Treatments...(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10375057.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
University of Colorado Cancer Center Study Shows the Preferred Feeding...
Parents and pediatric patients prefer IV feeding over tube feeding, despite medical benefits of tube feeding.(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10429284.htm
Source: PRWeb: Medical Pharmaceuticals - February 14, 2013 Category: Pharmaceuticals Source Type: news
Patients Urged to Watch for Trouble After Colon Surgery
Title: Patients Urged to Watch for Trouble After Colon SurgeryCategory: Health NewsCreated: 2/13/2013 2:36:00 PMLast Editorial Review: 2/14/2013 12:00:00 AM
Source: MedicineNet Cancer General - February 14, 2013 Category: Cancer & Oncology Source Type: news
Cancer danger: 10 Everyday items to ditch
Cancer remains to be at the top of the list of the most common causes of fatalities. This fatal disease can affect anyone. And there are everyday items that increase the risk of cancer. These items include the following:
Cellular phonesThere is still an ongoing debate...
Source: NaturalNews.com - February 14, 2013 Category: Consumer Health Advice Source Type: news
Is the Komen Foundation running to find a cure or to find more money for itself?
February is Cancer Prevention Month, though you might never guess it given the lack of publicity compared to attention given to the non-profits who focus on "finding a cure" as part of "Cancer Awareness" campaigns. The biggest of all the cancer non-profits is the Susan...
Source: NaturalNews.com - February 14, 2013 Category: Consumer Health Advice Source Type: news
Even a Drink a Day Boosts Cancer Death Risk, Alcohol Study Finds
The first update of alcohol-linked cancer deaths in the U.S. in three decades shows that booze can be blamed for nearly 20,000 deaths a year -- and it’s not just the heavy drinkers. Certainly those who downed three or more drinks a day accounted for most of the deaths from seven kinds of cancer, up to 60 percent, according to a new study published in the American Journal of Public Health.
Source: RWJF News Digest - Public Health - February 14, 2013 Category: American Health Source Type: news
Alcohol a Major Contributor to Cancer Mortality in U.S.
Source: Physician's First Watch current issue - February 14, 2013 Category: Primary Care Tags: Medical News Source Type: news
No difference in overall survival reported in phase III TIVO-1 study of tivozanib vs. sorafenib for advanced renal cell carcinoma
Source: BioSpace
Area: News
AVEO Oncology and Astellas Pharma Inc. have announced overall survival (OS) data (secondary endpoint) for tivozanib, an oral, once-daily, investigational tyrosine kinase inhibitor, from the phase III TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final analysis shows a median OS of 28.8 months (95% CI: 22.5-NA) for tivozanib vs. 29.3 months (29.3 to NA) for the comparator arm, sorafenib. No statistical difference between the two arms (hazard ratio 1.245, p=0.105) was observed.
TIVO-1 is a global, randomise...
Source: NeLM - News - February 14, 2013 Category: Drugs & Pharmacology Source Type: news
Australia launches national scheme to vaccinate boys against HPV
Source: BMJ
Area: News
According to a BMJ news report, Australia has started to vaccinate boys against human papillomavirus (HPV), making it the first country in the world to publicly fund HPV vaccination of this group, in a bid to protect against genital warts and anal, penile, and throat cancers. Starting in February, they will receive three doses of the quadrivalent vaccine Gardasil at ages 12-13, as part of a national, federally funded school based programme. A catch-up scheme will also run for 14-15 year old boys until the end of the school year in 2014. It will cost the federal government £13.8m over four years, in...
Source: NeLM - News - February 14, 2013 Category: Drugs & Pharmacology Source Type: news
BNF and BNF for Children update for health professionals February 2013
Source: BNF
Area: News
The following information has been updated in the BNF and/or BNF for Children:
BNF update
. Paracetamol poisoning [updated advice on management], Emergency Treatment of Poisoning
. Ivabradine for the treatment of chronic heart failure [NICE guidance], section 2.6.3
. Mannitol dry powder for inhalation for treating cystic fibrosis [NICE guidance], section 3.7
. Treatment of hereditary angioedema updated, section 3.4.3
. Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours [NICE guidance], section 6.6.2...
Source: NeLM - News - February 14, 2013 Category: Drugs & Pharmacology Source Type: news
Phase II trial: Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer
Source: Lancet Oncology
Area: News
Inhibition of oestrogen receptor is a mainstay of treatment for oestrogen-receptor-positive breast cancer but intrinsic and acquired resistance undermine the long-term effectiveness of endocrine treatments and lead to relapses in early stage disease. This has led to a drive to develop targeted therapies and integrate them into existing treatment strategies. Oestrogen receptor signalling is linked to many other cell signalling pathways, including those related to growth hormones and insulin-like growth factor (IGF). IGF-1 and IGF-2 bind to the IGF-1 receptor (IGF-1R), increasing cell prol...
Source: NeLM - News - February 14, 2013 Category: Drugs & Pharmacology Source Type: news
Alcohol Blamed for 1 in Every 30 Cancer Deaths: Study
Research suggests that even a little drinking can raise odds for malignancy
Source: The Doctors Lounge - Oncology - February 14, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Dependence, Preventive Medicine, News, Source Type: news
